Precision Autoimmune Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$20.9M
- Investors
-
3
Precision Autoimmune Therapeutics General Information
Description
Developer of innovative drugs intended to treat autoimmune diseases. The company develops cell therapy and innovative drugs for precision treatment of autoimmune and inflammatory diseases, enabling patients to get better treatment.
Contact Information
Corporate Office
- Floor 1-101-31, Building 2, Yard 1, Jiuqiao Road
- Beijing Economic and Technological Development Zone
- Beijing
- China
Corporate Office
- Floor 1-101-31, Building 2, Yard 1, Jiuqiao Road
- Beijing Economic and Technological Development Zone
- Beijing
- China
Precision Autoimmune Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 05-Jul-2022 | $20.9M | Completed | Pre-Clinical Trials |
Precision Autoimmune Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CASI Pharmaceuticals | Corporation | Minority | ||
| Emerging Technology Partners (Venture Capital) | Venture Capital | Minority | ||
| Redhill Capital | Growth/Expansion | Minority |
Precision Autoimmune Therapeutics FAQs
-
When was Precision Autoimmune Therapeutics founded?
Precision Autoimmune Therapeutics was founded in 2022.
-
Where is Precision Autoimmune Therapeutics headquartered?
Precision Autoimmune Therapeutics is headquartered in Beijing, China.
-
What industry is Precision Autoimmune Therapeutics in?
Precision Autoimmune Therapeutics’s primary industry is Drug Discovery.
-
Is Precision Autoimmune Therapeutics a private or public company?
Precision Autoimmune Therapeutics is a Private company.
-
What is Precision Autoimmune Therapeutics’s current revenue?
The current revenue for Precision Autoimmune Therapeutics is .
-
How much funding has Precision Autoimmune Therapeutics raised over time?
Precision Autoimmune Therapeutics has raised $20.9M.
-
Who are Precision Autoimmune Therapeutics’s investors?
CASI Pharmaceuticals, Emerging Technology Partners (Venture Capital), and Redhill Capital have invested in Precision Autoimmune Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process